0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Journal Articles

in Osteoporosis/Metabolic Bone Disease

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Internal Medicine
Invited Commentary  | 
Bone Density and Bone Turnover Marker Monitoring After Discontinuation of Alendronate Therapy:  An Evidence-Based Decision to Do Less
Margaret L. Gourlay, MD, MPH; Kristine E. Ensrud, MD, MPH
JAMA Internal Medicine
Original Investigation  | 
Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy:  The FLEX Study
Douglas C. Bauer, MD; Ann Schwartz, PhD; Lisa Palermo, MA, MS; et al.
JAMA
Viewpoint  | 
Is Big Data the New Frontier for Academic-Industry Collaboration?
Sachin H. Jain, MD, MBA; Michael Rosenblatt, MD; Jon Duke, MD, MS
JAMA Internal Medicine
Perspective  | 
A Dual-Energy X-ray Absorptiometry Scan:  Need to Know vs Nice to Know
Lorna A. Lynn, MD